5 '-Nucleotidase (CN-II) emerges as a new predictive biomarker of response in the gemcitabine-cisplatin treatment of non-small cell lung cancer

5 '-Nucleotidase (CN-II) emerges as a new predictive biomarker of response in the gemcitabine-cisplatin treatment of non-small cell lung cancer / F. Toffalorio, T. De Pas, E. Giovannetti, D. Radice, G. Spitaleri, D. Galetta, M. Manzotti, R. Danesi, G. Pelosi, L. Spaggiari, F. De Braud. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 6:Suppl. 2(2011), pp. S1023-S1023. (Intervento presentato al 14. convegno World Conference on Lung Cancer tenutosi a Amsterdam nel 2011).